Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm

Cardiology Journal

Volumn 21, Issue 3, 2014, Pages 309-315

  Jȩdrzejczyk Patej, Ewa ^a   Lenarczyk, Radosław ^a   Pruszkowska, Patrycja ^a   Kowalski, Oskar ^a   Mazurek, Michał ^a   Sokal, Adam ^a   Boidol, Joanna ^a   Woźniak, Aleksandra ^a   Pluta, Sławomir ^a   Szulik, Mariola ^a   Liberska, Agnieszka ^a   Kalarus, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Atrial fibrillation; Cardiac resynchronization; Heart failure; Junction ablation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ABLATION THERAPY; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; ECHOCARDIOGRAPHY; ELECTRODE IMPLANT; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PACEMAKER; SINUS RHYTHM; TREATMENT RESPONSE; ATRIAL FIBRILLATION; CATHETER ABLATION; EPIDEMIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; POLAND; PROCEDURES; PROSPECTIVE STUDY; SURGERY; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

AGED; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLAND; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902214178     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2013.0110     Document Type: Article

References (21)

1. Anand IS, Carson P, Galle E et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defbrillation in Heart Failure (COMPANION) trial. Circulation, 2009; 119: 969-977.
2. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005; 352: 1539-1549.
3. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C.; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol, 2008; 52: 1834-1843.
4. Moss AJ, Hall WJ, Cannom DS et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med, 2009; 361: 1329-1338.
5. Tang AS, Wells GA, Talajic M et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med, 2010; 363: 2385-2395.
6. Fornwalt BK, Sprague W W, BeDell P et al. Agreement is poor among current criteria used to defne response to cardiac resyn chronization therapy. Circulation, 2010; 121:1985-1991.
7. Smit MD, Maass AH, Hillege HL, Wiesfeld AC, Van Veldhuisen DJ, Van Gelder IC. Prognostic importance of natriuretic peptides and atrial fbrillation in patients receiving cardiac resynchronization therapy. Eur J Heart Fail, 2011; 13: 543-550.
8. Borleffs CJ, Ypenburg C, van Bommel RJ et al. Clinical importance of new-onset atrial fbrillation after cardiac resynchronization therapy. Heart Rhythm, 2009; 6: 305-310.
9. McMurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Car-diology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail, 2012; 14: 803-869.
10. Mele D, Pasanisi G, Capasso F et al. Left intraventricular my-ocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. Eur Heart J, 2006; 27: 1070-1078.
11. Vanderheyden M, De Backer T, Rivero-Ayerza M et al. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchro-nization therapy. Heart Rhythm, 2005; 2: 1066-1072.
12. Gasparini M, Auricchio A, Metra M et al. Long-term survival in patients undergoing cardiac resynchronization therapy: The importance of performing atrio-ventricular junction ablation in patients with permanent atrial fbrillation. Eur Heart J, 2008; 29: 1644-1652.
13. Molhoek SG, Bax JJ, Bleeker GB et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fbrillation. Am J Cardiol, 2004; 94: 1506-1509.
14. Tolosana JM, Hernandez Madrid A, Brugada J et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm. (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Am J Cardiol, 2008; 102: 444-449.
15. Ferreira AM, Adragao P, Cavaco DM et al. Beneft of cardiac resynchronization therapy in atrial fbrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace, 2008; 10: 809-815.
16. Hayes DL, Boehmer JP, Day J et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm, 2011; 8: 1469-1475.
17. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: Is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol, 2009; 53: 355-360.
18. Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fbrillation and heart failure: A systematic review. J Am Coll Cardiol, 2012; 59: 719-726.
19. Wang TJ, Larson MG, Levy D et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation, 2003; 107: 2920-2925.
20. Wilton SB, Leung AA, Ghali WA, Faris P, Exner D V. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fbrillation: A systematic review and meta-analysis. Heart Rhythm, 2011; 8: 1088-1094.
21. Tolosana JM, Arnau AM, Madrid AH et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response? Eur J Heart Fail, 2012; 14: 635-641.